Rocket Pharmaceuticals, Inc.

/Rocket Pharmaceuticals, Inc.

Secondary

Rocket Pharmaceuticals, Inc.

They an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases.

Symbol

RCKT

Last Closing Price
$15.19

Shares
3,700,000

Effective Date
January 24, 2018

Underwriters
Cowen, Evercore ISI

To view the prospectus for Rocket Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277